BridgeBio Pharma, Inc. is a company in the U.S. stock market and it is a holding in 50 U.S.-traded ETFs. BBIO has around 14.5M shares in the U.S. ETF market. The largest ETF holder of BBIO is the SPDR S&P Biotech ETF (XBI), with approximately 5.23M shares. Investors may also find of interest that the ETF with the largest allocation to BBIO stock is Direxion Moonshot Innovators ETF (MOON), with a portfolio weight of 2.91%. On average, U.S. ETFs allocate 0.22% of BBIO to their portfolios.
Additionally, BBIO is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BBIO as a holding is the Nationwide Russell 2000 Risk-Managed Income ETF (NTKI), with a return of --.